Skip to main content
SNAP Update and Resources Actualización y recursos de SNAP

On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more

El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

Updated: Medicaid Preferred Drug List and Formulary Changes

Date: January 18, 2024

Attention: All Providers

Effective Date: January 26, 2024

This is an update for a communication that was previously posted on 12/18/2023.

Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective January  26, 2024, select medication(s) moved from “preferred” or “non-reviewed” to “non-preferred” status. A summary of the changes is included below.

Resource: https://www.txvendordrug.com/formulary/preferred-drugs

Changes with biggest impact to Texas Children Health Plan members and providers: The drugs listed below were either not previously reviewed (NR) and became non-preferred (NPD) or previously considered a preferred agent (PDL) but now have changed status to non-preferred.

Impacted MedicationStatus ChangeTypePreferred Alternative
Accrufer [B]NR to NPDIron, oral 
Clemastine Syrup  [G]NR to NPDAntihistamineCyproheptadine Syrup [G] ^
Cosentyx Unoready Pen (SQ) [B]NR to NPDCytokine and Cam AntagonistsCosentyx Syringe [G]*
Cyltezo (SQ) [B]NR to NPDCytokine and Cam AntagonistsHumira [B] ^ *, Otezla [B] ^ *, Enbrel [B] ^ *
Eryped 200 Suspension [B]PDL to NPDMacrolides/KetolidesErythromycin Suspension [G]
Fiasp Pumcart (SQ) [B]NR to NPDInsulinFiasp Flextouch Pen [B] * , Insulin Aspart Pen [G] *, Fiasp Penfill [B] *
Konvomep (ORAL) [B]NR to NPDProton Pump InhibitorProtonix (pantoprazole) suspension [B]
Latuda (ORAL) [B]PDL to NPDAntipsychoticsOlanzapine [G] ^ *, Ziprasidone [G] ^ *
Miebo (OPTH) [B]NR to NPDEye DropsRestasis [B] ^ *, Xiidra [B] ^ *
Ngenla (SQ) [B]NR to NPDGrowth HormoneOmnitrope [B] ^ *, Skytrofa [B] ^ *
Noxafil (ORAL) [B]PDL to NPDAntibioticsPosaconazole [G]
Rezvoglar (SQ) [B]NR to NPDInsulinLantus Solostar Pen (SQ) [B]
Sogroya (SQ) [B]NR to NPDGrowth HormoneOmnitrope [B] ^ *, Skytrofa [B] ^ *
Udenyca (SQ) [B]NR to NPDColony Stimulating FactorNyvepria [B] ^ *
Verkazia  (OPTH) [B]NR to NPDEye DropsRestasis [B] *
Vigamox (OPTH) [B]PDL to NPDEye Drops AntibioticsMoxifloxacin (OPTH) [G]*

*In addition to PDL, these medications also have a clinical prior authorization requirement.
^This is a suggested alternative. Please discuss these options with your provider to determine therapy.
[B] Signals the medication is brand.
[G] Signals the medication is generic.
NR stands for Not Reviewed
PDL stands for Preferred Drug List
NPD stands for Non-Preferred Drug

How this impacts providers: Preferred and non-preferred medications may continue to require clinical prior authorizations. In addition to any clinical prior authorization requirements, non-preferred medications will also require a “step therapy prior authorization.” Non-preferred drugs on the formulary require prior approval and are only approved when there is clinical justification as to why the patient cannot use the preferred drug, including failure/side effects or contraindications to the preferred agents. This means that members must have attempted and failed at least one preferred medication before obtaining a non-preferred medication. The preferred drug list (PDL) can be found on the VDP website https://www.txvendordrug.com/formulary/preferred-drugs. Medicaid managed care plans are required to follow the PDL.

Next steps for providers:  Preferred drugs are medications recommended by the Texas Drug Utilization Review Board for their efficaciousness, clinical significance, cost effectiveness, and safety. Texas Children’s Health Plan encourages providers to initiate a preferred medication to members new to therapy. When possible, Texas Children’s Health Plan also encourages switching existing members to a preferred agent.

If you have any questions, please email TCHP Pharmacy Department at: TCHPPharmacy@texaschildrens.org

For access to all provider alerts,log into: www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.